Pioglitazone 15 mg or 30 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pioglitazone 15 mg or 30 mg, covering 2023-05-24 to 2023-05-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin [Phase 3]